Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
1.110
-0.060 (-5.13%)
Feb 6, 2025, 4:00 PM EST - Market closed
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $61.09 million as of February 6, 2025. Its market cap has decreased by -70.48% in one year.
Market Cap
61.09M
Enterprise Value
-71.10M
1-Year Change
-70.48%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $61.09M, a decrease of -92.43%. That is a compound annual growth rate of -44.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2025 | 64.39M | -8.24% |
| Dec 31, 2024 | 70.17M | -73.80% |
| Dec 29, 2023 | 267.79M | -6.83% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | 3.03B | 276.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.74B |
| UnitedHealth Group | 504.48B |
| Novo Nordisk | 367.70B |
| Johnson & Johnson | 365.65B |
| AbbVie | 336.00B |
| Merck & Co. | 252.43B |
| Thermo Fisher Scientific | 227.11B |
| Abbott Laboratories | 222.79B |